|
|
The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy. |
Clearwater
| |||
C8: Current Issues in Genital Herpes and Human Papillomavirus Prevention | |||
| 10:00 AM | 227 | Does clinical severity of genital herpes predict risk of transmission? Analysis of the Valacyclovir Transmission Study H. Nina Kim, Anna Wald, Julia Harris, Jennifer L. Almekinder, Cathy Heitman, Lawrence Corey | |
| 10:15 AM | 228 | Single-day episodic treatment of recurrent genital herpes using famciclovir: Implications for public health practice Gary A. Richwald, Peter A. Leone, Stephen Tyring, Kamal Hamed | |
| 10:30 AM | 229 | Estimating the incidence of neonatal herpes infection in New York City, 1994-2003; implications for formulating a national case definition Julia A. Schillinger, Ellen Klingler, Preeti Pathela, Anna Battat, Hwa-Gan Chang, Eric Friedenberg, Bonnie Kerker, Perry Smith, Susan Blank | |
| 10:45 AM | 230 | Concordance in Decision Making for STD Vaccination Between Parents and Adolescents Beth E. Juliar, Rita M. Bair, Gregory D. Zimet, Lynne A. Sturm, Rose M. Mays, Susan M. Perkins | |
| 11:00 AM | 231 | Effect of a Cervical High-Risk Human Papillomavirus (HR-HPV) Diagnosis on Women's Sexuality in Los Angeles Bita Amani, Pamina Gorbach, Angela Shin, Ross Cranston, Janet St. Lawrence, Peter Kerndt | |
| 11:15 AM | 232 | Promoting General Awareness of HPV, its Link to Cancer and Genital Warts: A Social Marketing Approach Allison L. Friedman, Eileen F. Dunne, Hilda Shepeard | |